Optiver Holding’s NeoGenomics NEO Stock Holding History

Optiver Holding’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-198	Closed	-$1.53K	–	2799
2025 Q3	$1.53K	Buy	+198	New	+$1.39K	﹤0.01%	2448

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Optiver Holding's NEO Position: Q4 2025 in Review

Optiver Holding sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 198 shares — an estimated $1.53K sold.

Optiver Holding first reported a position in NEO in Q3 2025 and held it in 1 quarter. The position peaked at $1.53K in Q3 2025. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

Optiver Holding reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 198 NeoGenomics shares in Q4 2025, an estimated $1.53K.
Optiver Holding first reported a position in NeoGenomics in Q3 2025 and held it in 1 quarter.
Optiver Holding's NeoGenomics position peaked at $1.53K in Q3 2025.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.